{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-025811","form_type":"8-K","ticker":"NMTC","cik":"0001500198","company_name":"NEUROONE MEDICAL TECHNOLOGIES Corp","filed_at":"2024-03-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.352165+00:00","generated_at":"2026-06-04T07:49:28.871996+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"NeuroOne Medical Technologies starts limited commercial launch of OneRF Ablation System","bullets":["OneRF System is FDA 510(k)-cleared for creating RF lesions in nervous tissue for functional neurosurgery.","CEO Dave Rosa expects shipping to begin this week with first cases scheduled in April 2024.","First therapeutic device for NeuroOne; third FDA 510(k)-cleared device alongside Evo electrode lines.","Company estimates the brain ablation market at least $100M worldwide with significant growth potential."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-025811","json":"https://secwatch.observer/filing/0001213900-24-025811.json","markdown":"https://secwatch.observer/filing/0001213900-24-025811.md","text":"https://secwatch.observer/filing/0001213900-24-025811.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1500198/000121390024025811/0001213900-24-025811-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1500198/000121390024025811/ea0202492-8k_neuro.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T07:49:28.871996+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}